The global Orthobiologics market is estimated to be valued at US$ 6,515.2 million in 2022 and is expected to exhibit a CAGR of 5.9% over the forecast period 2022-2030, as highlighted in a new report published by Coherent Market Insights.
Orthobiologics refer to the use of biological substances to promote the healing and regeneration of musculoskeletal tissues, such as bones, cartilage, tendons,...
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian